Search Results1-18 of  18

  • Shitara Kohei ID: 9000018934091

    Articles in CiNii:1

    • Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer (2012)
  • Shitara Kohei ID: 9000019002841

    Articles in CiNii:1

    • Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1 : multi-institutional retrospective analysis (2012)
  • Shitara Kohei ID: 9000024950117

    Articles in CiNii:1

    • Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis (2013)
  • Shitara Kohei ID: 9000241506045

    Articles in CiNii:1

    • Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment (2013)
  • Shitara Kohei ID: 9000264861943

    Articles in CiNii:1

    • Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancer (2014)
  • Shitara Kohei ID: 9000329006933

    Articles in CiNii:1

    • Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW : a randomized clinical trial in second-line treatment of gastric cancer (2016)
  • Shitara Kohei ID: 9000342443676

    Articles in CiNii:1

    • Phase Ⅱ study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage Ⅲ gastric cancer after D2 gastrectomy (2017)
  • Shitara Kohei ID: 9000346917095

    Articles in CiNii:1

    • Chemotherapy for advanced gastric cancer : future perspective in Japan (Gastric Cancer : Asia and the World : From the 88th JGCA Annual Meeting) (2017)
  • Shitara Kohei ID: 9000347541951

    Articles in CiNii:1

    • Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G (2016)
  • Shitara Kohei ID: 9000356547270

    Articles in CiNii:1

    • Dose-escalation study for the targeting of CD44v⁺ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205) (2017)
  • Shitara Kohei ID: 9000356647878

    Articles in CiNii:1

    • Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients (2017)
  • Shitara Kohei ID: 9000368919697

    Articles in CiNii:1

    • Current management of liver metastases from gastric cancer : what is common practice? New challenge of EORTC and JCOG (2017)
  • Shitara Kohei ID: 9000375852846

    Articles in CiNii:1

    • Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407) (2017)
  • Shitara Kohei ID: 9000380492849

    Articles in CiNii:1

    • Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naive metastatic gastric/gastroesophageal junction cancer (2018)
  • Shitara Kohei ID: 9000399574752

    Articles in CiNii:1

    • Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer (2019)
  • Shitara Kohei ID: 9000399574878

    Articles in CiNii:1

    • Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer : an exploratory analysis of the phase Ⅲ ABSOLUTE trial (2019)
  • Shitara Kohei ID: 9000401420746

    Articles in CiNii:1

    • Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples (2019)
  • Shitara Kohei ID: 9000273023938

    Department of Gastrointestinal Oncology National Cancer Center East Hospital|Department of Experimental Therapeutics National Cancer Center East Hospital (2014 from CiNii)

    Articles in CiNii:1

    • Future Perspective of Chemotherapy for Colorectal Cancer (2014)
Page Top